Organic Process Research & Development · 2007 · 26 citations · 8 references
EngineeringChemical EngineeringChemistryPharmaceutical ManufacturingReaction EngineeringSynthetic Medicinal ChemistryEnzyme InhibitionProcess SynthesisSafer Chemical SynthesisBenzimidazole SynthesisChemical Synthesis PlanningEnzyme Inhibitor SynthesisImpuritiesMedicinal Chemistry ApplicationsProduct Development Process
A nine-step convergent process was developed for the synthesis of ABT-472, a benzimidazole PARP inhibitor. The identity and origin of several impurities were determined, and the process was modified to reduce or eliminate these impurities. A number of safety and control issues were investigated. The original synthesis was shortened to 9 steps and streamlined while maintaining a convergent strategy. A stable salt was selected, and control of the API solid form was established. The process was successfully scaled up to provide 8.5 kg of final product of >99% purity in 33% yield over 9 steps.
8
William A. Denny, Gordon W. Rewcastle, Bruce C. Baguley · Journal of Medicinal Chemistry · 1990 · 309 citations
International Union of Pure and Applied Chemistry (IUPAC)
Shiro Ikegami · TRENDS IN THE SCIENCES · 2002 · 151 citations · Full text
Kinetics of Hypobromous Acid Disproportionation
Richard C. Beckwith, Dale W. Margerum · Inorganic Chemistry · 1997 · 55 citations